{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:08:41Z","timestamp":1790636921744,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371104"],"award-info":[{"award-number":["82371104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30851"],"award-info":[{"award-number":["2023JJ30851"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02839-x","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:19:16Z","timestamp":1772435956000},"page":"1519-1534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biglycan knockdown improves Graves\u2019 orbitopathy (GO)-like features via inhibiting NF-kB and ERK signaling"],"prefix":"10.1007","volume":"49","author":[{"given":"Changci","family":"Chenzhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3017-9895","authenticated-orcid":false,"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"7","key":"2839_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S2213-8587(25)00066-X","volume":"13","author":"WM Wiersinga","year":"2025","unstructured":"Wiersinga WM, Eckstein AK, \u017darkovi\u0107 M (2025) Thyroid eye disease (Graves\u2019 orbitopathy): clinical presentation, epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol 13(7):600\u2013614","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2839_CR2","doi-asserted-by":"crossref","unstructured":"Lee ACH, Kahaly GJ (2025) Unravelling the pathogenic mechanisms in Graves\u2019 orbitopathy. Eur Thyroid J 14(5): e250200","DOI":"10.1530\/ETJ-25-0200"},{"issue":"4","key":"2839_CR3","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L et al (2021) The 2021 European group on graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves\u2019 orbitopathy. Eur J Endocrinol 185(4):G43\u2013g67","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2839_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS et al (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382(4):341\u2013352","journal-title":"N Engl J Med"},{"issue":"4","key":"2839_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/IOP.0000000000002573","volume":"40","author":"AF Duarte","year":"2024","unstructured":"Duarte AF et al (2024) Efficiency and safety of Tocilizumab for the treatment of thyroid eye disease: A systematic review. Ophthalmic Plast Reconstr Surg 40(4):367\u2013373","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2839_CR6","doi-asserted-by":"crossref","unstructured":"Chiu HI, Wu SB, Tsai CC (2024) The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves\u2019 Ophthalmopathy. Int J Mol Sci 25(6) :3288","DOI":"10.3390\/ijms25063288"},{"key":"2839_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","volume":"142","author":"WA Dik","year":"2016","unstructured":"Dik WA, Virakul S, van Steensel L (2016) Current perspectives on the role of orbital fibroblasts in the pathogenesis of graves\u2019 ophthalmopathy. Exp Eye Res 142:83\u201391","journal-title":"Exp Eye Res"},{"key":"2839_CR8","first-page":"251584142110277","volume":"13","author":"CJ Men","year":"2021","unstructured":"Men CJ, Kossler AL, Wester ST (2021) Updates on the Understanding and management of thyroid eye disease. Ther Adv Ophthalmol 13:25158414211027760","journal-title":"Ther Adv Ophthalmol"},{"key":"2839_CR9","doi-asserted-by":"crossref","unstructured":"Schulz M et al (2021) Biglycan: A regulator of hepatorenal inflammation and autophagy. Matrix Biol 100: 150\u2013161","DOI":"10.1016\/j.matbio.2021.06.001"},{"key":"2839_CR10","doi-asserted-by":"crossref","unstructured":"Cengiz M, Yilmaz G, Ozenirler S (2021) Serum Biglycan as a diagnostic marker for Non-Alcoholic steatohepatitis and liver fibrosis. Clin Lab 67(3):804\u2013 820","DOI":"10.7754\/Clin.Lab.2020.200709"},{"key":"2839_CR11","doi-asserted-by":"crossref","unstructured":"Scuruchi M et al (2023) Biglycan involvement in heart fibrosis: modulation of adenosine 2A receptor improves damage in immortalized cardiac fibroblasts. Int J Mol Sci 24(2) :1784","DOI":"10.3390\/ijms24021784"},{"key":"2839_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biocel.2014.07.020","volume":"54","author":"LT Hsieh","year":"2014","unstructured":"Hsieh LT et al (2014) Soluble Biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol 54:223\u2013235","journal-title":"Int J Biochem Cell Biol"},{"key":"2839_CR13","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.mbplus.2019.04.002","volume":"1","author":"J Merl-Pham","year":"2019","unstructured":"Merl-Pham J et al (2019) Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an in vitro model of lung fibrosis. Matrix Biol Plus 1:100005","journal-title":"Matrix Biol Plus"},{"key":"2839_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.yjmcc.2016.10.011","volume":"101","author":"N Beetz","year":"2016","unstructured":"Beetz N et al (2016) Ablation of Biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload. J Mol Cell Cardiol 101:145\u2013155","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"2839_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/liv.15477","volume":"43","author":"M Yu","year":"2023","unstructured":"Yu M et al (2023) Biglycan promotes hepatic fibrosis through activating heat shock protein 47. Liver Int 43(2):500\u2013512","journal-title":"Liver Int"},{"issue":"1","key":"2839_CR16","doi-asserted-by":"publisher","first-page":"2020984","DOI":"10.1080\/2162402X.2021.2020984","volume":"11","author":"S Zheng","year":"2022","unstructured":"Zheng S et al (2022) Landscape of cancer-associated fibroblasts identifies the secreted Biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer. Oncoimmunology 11(1):2020984","journal-title":"Oncoimmunology"},{"issue":"13","key":"2839_CR17","doi-asserted-by":"publisher","first-page":"107818","DOI":"10.1016\/j.celrep.2020.107818","volume":"31","author":"CY Han","year":"2020","unstructured":"Han CY et al (2020) Adipocyte-Derived versican and Macrophage-Derived Biglycan control adipose tissue inflammation in obesity. Cell Rep 31(13):107818","journal-title":"Cell Rep"},{"issue":"1","key":"2839_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/03008207.2012.715700","volume":"54","author":"T Tang","year":"2013","unstructured":"Tang T et al (2013) Decreased body fat, elevated plasma transforming growth factor-\u03b2 levels, and impaired BMP4-like signaling in biglycan-deficient mice. Connect Tissue Res 54(1):5\u201313","journal-title":"Connect Tissue Res"},{"key":"2839_CR19","doi-asserted-by":"publisher","first-page":"109457","DOI":"10.1016\/j.exer.2023.109457","volume":"230","author":"P Peng","year":"2023","unstructured":"Peng P et al (2023) Proteomic characterization of aqueous humor in corneal endothelial decompensation after penetrating keratoplasty. Exp Eye Res 230:109457","journal-title":"Exp Eye Res"},{"key":"2839_CR20","doi-asserted-by":"crossref","unstructured":"Abdallah BM, Ali EM (2020) Butein promotes lineage commitment of bone Marrow-Derived stem cells into osteoblasts via modulating ERK1\/2 signaling pathways. Molecules 25(8) :1885","DOI":"10.3390\/molecules25081885"},{"issue":"11","key":"2839_CR21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jamaophthalmol.2017.3458","volume":"135","author":"JT Rosenbaum","year":"2017","unstructured":"Rosenbaum JT et al (2017) Gene expression profiling and heterogeneity of nonspecific orbital inflammation affecting the lacrimal gland. JAMA Ophthalmol 135(11):1156\u20131162","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"2839_CR22","doi-asserted-by":"publisher","first-page":"100699","DOI":"10.1016\/j.xcrm.2022.100699","volume":"3","author":"Z Li","year":"2022","unstructured":"Li Z et al (2022) Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. Cell Rep Med 3(8):100699","journal-title":"Cell Rep Med"},{"issue":"10","key":"2839_CR23","doi-asserted-by":"publisher","first-page":"e38000","DOI":"10.1002\/jbm.a.38000","volume":"113","author":"B Xie","year":"2025","unstructured":"Xie B et al (2025) Triamcinolone acetonide (TCA)-Loaded biodegradable microspheres improve therapeutic outcomes in Thyroid-Associated ophthalmopathy (TAO) by reducing fibrosis and adipogenesis. J Biomed Mater Res A 113(10):e38000","journal-title":"J Biomed Mater Res A"},{"key":"2839_CR24","doi-asserted-by":"crossref","unstructured":"Van Tin H et al (2024) Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-\u03baB Signaling. Cells 13(16)","DOI":"10.3390\/cells13161331"},{"key":"2839_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.reth.2025.07.002","volume":"30","author":"Y Shao","year":"2025","unstructured":"Shao Y et al (2025) Human growth hormone-overexpressing adipose-derived stem cells enhance fibroblast activity and accelerate burn wound healing via ERK pathway therapeutic potential of ADSCs in burn wound repair. Regen Ther 30:465\u2013475","journal-title":"Regen Ther"},{"issue":"1","key":"2839_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12967-023-04217-0","volume":"21","author":"Y Chen","year":"2023","unstructured":"Chen Y et al (2023) RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse. J Transl Med 21(1):396","journal-title":"J Transl Med"},{"issue":"11","key":"2839_CR27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41419-020-03178-2","volume":"11","author":"L Peng","year":"2020","unstructured":"Peng L et al (2020) Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death Dis 11(11):978","journal-title":"Cell Death Dis"},{"issue":"3","key":"2839_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/thy.2021.0246","volume":"32","author":"X Wang","year":"2022","unstructured":"Wang X et al (2022) Disulfiram exerts Antiadipogenic, Anti-Inflammatory, and antifibrotic therapeutic effects in an in vitro model of graves\u2019 orbitopathy. Thyroid 32(3):294\u2013305","journal-title":"Thyroid"},{"issue":"11","key":"2839_CR29","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1248\/bpb.33.1891","volume":"33","author":"X Wang","year":"2010","unstructured":"Wang X et al (2010) Matrix protein Biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways. Biol Pharm Bull 33(11):1891\u20131897","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"2839_CR30","doi-asserted-by":"publisher","first-page":"e28397","DOI":"10.1016\/j.heliyon.2024.e28397","volume":"10","author":"Y Wu","year":"2024","unstructured":"Wu Y et al (2024) Comparison of orbital fibroblasts from graves\u2019 ophthalmopathy and healthy control. Heliyon 10(7):e28397","journal-title":"Heliyon"},{"issue":"19","key":"2839_CR31","doi-asserted-by":"publisher","first-page":"17365","DOI":"10.1074\/jbc.M110.192682","volume":"286","author":"A Melchior-Becker","year":"2011","unstructured":"Melchior-Becker A et al (2011) Deficiency of Biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem 286(19):17365\u201317375","journal-title":"J Biol Chem"},{"issue":"3","key":"2839_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/03008200802148504","volume":"49","author":"E Bereczki","year":"2008","unstructured":"Bereczki E, Santha M (2008) The role of Biglycan in the heart. Connect Tissue Res 49(3):129\u2013132","journal-title":"Connect Tissue Res"},{"key":"2839_CR33","doi-asserted-by":"publisher","first-page":"900791","DOI":"10.3389\/fendo.2022.900791","volume":"13","author":"SY Jang","year":"2022","unstructured":"Jang SY et al (2022) Therapeutic potential of targeting Periostin in the treatment of graves\u2019 orbitopathy. Front Endocrinol (Lausanne) 13:900791","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2839_CR34","doi-asserted-by":"publisher","first-page":"e0221077","DOI":"10.1371\/journal.pone.0221077","volume":"14","author":"SY Jang","year":"2019","unstructured":"Jang SY et al (2019) MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with graves\u2019 orbitopathy. PLoS ONE 14(8):e0221077","journal-title":"PLoS ONE"},{"issue":"10","key":"2839_CR35","doi-asserted-by":"publisher","first-page":"e26261","DOI":"10.1371\/journal.pone.0026261","volume":"6","author":"JS Yoon","year":"2011","unstructured":"Yoon JS et al (2011) Quercetin inhibits IL-1beta-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from graves\u2019 orbitopathy. PLoS ONE 6(10):e26261","journal-title":"PLoS ONE"},{"key":"2839_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fendo.2018.00473","volume":"9","author":"X Ma","year":"2018","unstructured":"Ma X et al (2018) Deciphering the roles of PPARgamma in adipocytes via dynamic change of transcription complex. Front Endocrinol (Lausanne) 9:473","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"21","key":"2839_CR37","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1101\/gad.1709008","volume":"22","author":"MI Lefterova","year":"2008","unstructured":"Lefterova MI et al (2008) PPARgamma and C\/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22(21):2941\u20132952","journal-title":"Genes Dev"},{"issue":"4","key":"2839_CR38","doi-asserted-by":"publisher","first-page":"e0249988","DOI":"10.1371\/journal.pone.0249988","volume":"16","author":"SE Kim","year":"2021","unstructured":"Kim SE et al (2021) Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via Inhibition of the NF-kappaB pathway. PLoS ONE 16(4):e0249988","journal-title":"PLoS ONE"},{"issue":"10","key":"2839_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11655-023-3598-z","volume":"29","author":"J Yi","year":"2023","unstructured":"Yi J et al (2023) Polypeptide from moschus suppresses Lipopolysaccharide-Induced inflammation by inhibiting NF-\u03ba B-ROS\/NLRP3 pathway. Chin J Integr Med 29(10):895\u2013904","journal-title":"Chin J Integr Med"},{"key":"2839_CR40","doi-asserted-by":"crossref","unstructured":"Han HS et al (2023) Leuconostoc citreum inhibits adipogenesis and lipogenesis by inhibiting p38 MAPK\/Erk 44\/42 and stimulating AMPK\u03b1 signaling pathways. Int J Mol Sci 24(8):7367","DOI":"10.3390\/ijms24087367"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02839-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:25:04Z","timestamp":1786105504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02839-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["2839"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02839-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was obtained from the participants.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of Third Xiangya Hospital, Central South University (approval number: 2023-S130), and the 1964 Helsinki Declaration. Informed consent to participate in the study has been obtained from participants. The guidelines for the care and use of animals were approved by the Medicine Animal Welfare Committee of Third Xiangya Hospital, Central South University (approval number: 2023-S130).","order":3,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}